½ÃÀ庸°í¼­
»óǰÄÚµå
1402100

¼¼°èÀÇ ºÐÀÚ ÃøÁ¤¹ý ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2023-2030³â)

Global Molecular Methods Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 121 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ºÐÀÚ ÃøÁ¤¹ý ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â Á¶»ç ±â°£ÀÎ 2023-2030³â CAGR 7.29%·Î, 2022³â 26¾ï ´Þ·¯¿¡¼­ 2030³â¿¡´Â 45¾ï 7,000¸¸ ´Þ·¯ °¡±î¿î ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

ºÐÀÚ ÃøÁ¤¹ýÀº ºÐÀÚ »ý¹°ÇÐ ¹× »ýÈ­Çп¡¼­ »ýü ºÐÀÚ ¹× ±âŸ ¼¼Æ÷ ÄÄÆ÷³ÍÆ®ÀÇ ±¸Á¶, ±â´É ¹× »óÈ£ ÀÛ¿ëÀ» ºÐÀÚ ¼öÁØ¿¡¼­ ¿¬±¸ÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÏ·ÃÀÇ ±â¼ú ¹× ÀýÂ÷¸¦ ¸»ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¹æ¹ýÀº »ý¹°ÇÐÀû °úÁ¤, Áúº´, À¯ÀüÇÐ ¹× ´Ù¾çÇÑ °úÇÐ ºÐ¾ß¿¡¼­ ºÐÀÚÀÇ ¿ªÇÒÀ» ÀÌÇØÇϱâ À§ÇØ ºÐÀÚ¸¦ Á¶ÀÛÇÏ°í ºÐ¼®ÇÏ´Â °ÍÀ» Æ÷ÇÔÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ

±â¼úÀÇ ¹ßÀüÀº PCR, DNA ¿°±â¼­¿­ ºÐ¼® ¹× ±âŸ ±â¼úÀ» Áö¼ÓÀûÀ¸·Î ¹ßÀü½ÃÄÑ Á¤È®¼º°ú È¿À²¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϸ鼭 À¯ÀüÀÚ °Ë»ç ¹× °³ÀÎ À¯ÀüÀÚ ÇÁ·ÎÆÄÀÏ¿¡ ±â¹ÝÇÑ ¸ÂÃãÇü Ä¡·á¸¦ À§ÇØ ºÐÀÚÀû ¹æ¹ýÀ» äÅÃÇϸ鼭 ÀÌ ½ÃÀåÀÌ È°¼ºÈ­µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ COVID-19¿Í °°Àº Àü¿°º´ÀÇ À¯ÇàÀº ½Å¼ÓÇϰí Á¤È®ÇÑ Áø´ÜÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀåÀ» ´õ¿í °­È­½Ã۰í ÀÖ½À´Ï´Ù. ½Å¾à°³¹ß¿¡¼­ ºÐÀÚÀû ¹æ¹ýÀº Ç¥Àû ¹ß±¼ºÎÅÍ ÀÓ»ó½ÃÇè¿¡ À̸£±â±îÁö ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϸç Á¦¾à ¹× »ý¸í°øÇÐ ¿¬±¸¸¦ °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. À¯ÀüüÇÐ, ÇÁ·ÎÅ׿À¹Í½º, »ý¸í°úÇÐ ºÐ¾ßÀÇ ¿¬±¸ ±¸»ó È®´ë´Â ÅõÀÚ¿Í º¸Á¶±Ý¿¡ ÈûÀÔ¾î ÀÌ·¯ÇÑ ¹æ¹ý·ÐÀÇ Çõ½Å°ú äÅÃÀ» Áö¼ÓÀûÀ¸·Î ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÇöÀå °Ë»ç Àåºñ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ºñ¿ë È¿À²ÀûÀÎ ÀÚµ¿È­ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡µµ Å« ±â¿©¸¦ Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀ» Á¾ÇÕÇÏ¸é ºÐÀÚ °Ë»ç¹ý ½ÃÀåÀÇ ¼ºÀå ±Ëµµ¸¦ ÀÚ±ØÇÏ°í ºÐÀÚ »ý¹°ÇÐ ¹× °ü·Ã ºÐ¾ßÀÇ Áö¼ÓÀûÀÎ È®Àå°ú Çõ½ÅÀ» ±â´ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ Á¶»ç ¸®Æ÷Æ®´Â Porter's Five Forces ¸ðµ¨, ½ÃÀåÀÇ ¸Å·Â ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» äÅÃÇϰí ÀÖ½À´Ï´Ù. ÀÌ ÅøÀº ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇϰí, ¼¼°è ·¹º§¿¡¼­ÀÇ °æÀï ¸Å·ÂÀ» Æò°¡Çϴµ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ ÅøÀº ¼¼°èÀÇ ºÐÀÚ ÃøÁ¤¹ý ½ÃÀåÀÇ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼öµµ ÀÖ½À´Ï´Ù. ºÐÀÚ ÃøÁ¤¹ý »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ ÀüüÀûÀÎ ¾îÇÁ·ÎÄ¡¸¦ Á¦°øÇÕ´Ï´Ù.

Áö¿ª ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­ ºÐÀÚ ÃøÁ¤¹ý ½ÃÀå ÇöÀç ¹× ÇâÈÄ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ À¯¸íÇÑ Àü Áö¿ª¿¡¼­ °³º° ¾ÖÇø®ÄÉÀÌ¼Ç ºÎ¹®ÀÇ ¼ö¿ä¡¤ÃßÁ¤¡¤¿¹Ãø¿¡µµ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.

Ä¿½ºÅÒ ¿ä°ÇÀÌ ÀÖ´Â °æ¿ì ¹®ÀÇÇØÁֽñ⠹ٶø´Ï´Ù. Value Market ResearchÀÇ ¿¬±¸ÆÀÀÌ °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ½º³À¼ô

Á¦3Àå ºÐÀÚ ÃøÁ¤¹ý - »ê¾÷ ºÐ¼®

  • ¼­·Ð : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • ´ÙÀÌ·ºÆ® ¸¶ÄÉÆÃ
    • ÀδÙÀÌ·ºÆ® ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ºÐÀÚ ÃøÁ¤¹ý ½ÃÀå ºÐ¼® : ±â¼úº°

  • ±â¼úº° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ±â¼úº° ºÐ¼®
  • ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ(PCR)
  • ¸é¿ªÃøÁ¤¹ý
  • ¹ÙÀÌ¿À¼¾¼­
  • ¸¶ÀÌÅ©·Î¾î·¹ÀÌ
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ ºÐÀÚ ÃøÁ¤¹ý ½ÃÀå ºÐ¼® : Á¦Ç°º°

  • Á¦Ç°º° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • Á¦Ç°º° ºÐ¼®
  • ±â±â
  • ½Ã¾à¡¤¼Ò¸ðǰ
  • ¼­ºñ½º

Á¦7Àå ¼¼°èÀÇ ºÐÀÚ ÃøÁ¤¹ý ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼­·Ð
  • ºÏ¹Ì ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º° ÆÇ¸Å ºÐ¼®
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå ºÐÀÚ ÃøÁ¤¹ý ±â¾÷ÀÇ °æÀï ±¸µµ

  • ºÐÀÚ ÃøÁ¤¹ý ½ÃÀåÀÇ °æÀï
  • ÆÄÆ®³Ê½Ê/Á¦ÈÞ/ÇùÁ¤
  • ÇÕº´¡¤Àμö
  • ½ÅÁ¦Ç° Ãâ½Ã
  • ±âŸ °³¹ß

Á¦9Àå ±â¾÷ °³¿ä

  • »óÀ§ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • QIAGEN
  • 3M
  • Veredus Laboratories
  • NEOGEN CORPORATION
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • bioMerieux SA
  • ArcherDX Inc.
  • HiMedia Laboratories
  • Eurofins Scientific
  • SGS SA
KSA 24.01.11

The global demand for Molecular Methods Market is presumed to reach the market size of nearly USD 4.57 BN by 2030 from USD 2.6 BN in 2022 with a CAGR of 7.29% under the study period 2023 - 2030.

Molecular methods refer to a set of techniques and procedures used in molecular biology and biochemistry to study the structure, function, and interactions of biological molecules and other cellular components at the molecular level. These methods involve manipulating and analyzing molecules to understand their roles in biological processes, diseases, genetics, and various scientific fields.

MARKET DYNAMICS

Technological advancements stand at the forefront, constantly evolving PCR, DNA sequencing, and other techniques, enhancing accuracy and efficiency. The surge in demand for personalized medicine fuels this market, employing molecular methods for genetic testing and tailored treatments based on individual genetic profiles. Moreover, the prevalence of infectious diseases like COVID-19 amplifies the need for rapid and precise diagnostics, further bolstering the market. In drug discovery, molecular methods play a pivotal role, from target identification to clinical trials, accelerating pharmaceutical and biotech research. Expanding research initiatives in genomics, proteomics, and life sciences, fueled by investments and grants, continually drive innovation and adoption of these methods. The growing demand for point-of-care testing devices and the push for cost-effective, automated systems also contribute significantly. Collectively, these factors stimulate the molecular methods market's growth trajectory, promising ongoing expansion and innovation in molecular biology and related fields

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of molecular methods. The growth and trends of molecular methods industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the molecular methods market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

  • Polymerase Chain Reaction (PCR)
  • Immunoassay
  • Biosensors
  • Microarray
  • Others

By Product

  • Instrument
  • Reagents & Consumables
  • Services

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Molecular Methods market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Molecular Methods market include QIAGEN, 3M, Veredus Laboratories, NEOGEN CORPORATION, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., bioMerieux SA, ArcherDX, Inc., HiMedia Laboratories, Eurofins Scientific, SGS SA. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . MOLECULAR METHODS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Technology
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL MOLECULAR METHODS MARKET ANALYSIS BY TECHNOLOGY

  • 5.1 Overview by Technology
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Technology
  • 5.4 Polymerase Chain Reaction (PCR) Historic and Forecast Sales by Regions
  • 5.5 Immunoassay Historic and Forecast Sales by Regions
  • 5.6 Biosensors Historic and Forecast Sales by Regions
  • 5.7 Microarray Historic and Forecast Sales by Regions
  • 5.8 Others Historic and Forecast Sales by Regions

6 . GLOBAL MOLECULAR METHODS MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Instrument Historic and Forecast Sales by Regions
  • 6.5 Reagents & Consumables Historic and Forecast Sales by Regions
  • 6.6 Services Historic and Forecast Sales by Regions

7 . GLOBAL MOLECULAR METHODS MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. South East Asia Sales Analysis
    • 7.5.10. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE MOLECULAR METHODS COMPANIES

  • 8.1. Molecular Methods Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF MOLECULAR METHODS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. QIAGEN
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. 3M
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Veredus Laboratories
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. NEOGEN CORPORATION
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Bio-Rad Laboratories Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Thermo Fisher Scientific Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. bioMerieux SA
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. ArcherDX Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. HiMedia Laboratories
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. Eurofins Scientific
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. SGS SA
    • 9.13.1. Company Overview
    • 9.13.2. Company Revenue
    • 9.13.3. Products
    • 9.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦